Diaceutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Diaceutics generated cash of $1,311,000, which is less than the previous year. Cash used in financing activities reached the amount of -$239,000 last year. Net change in cash is therefore -$3,174,000.
Cash Flow
| 2015 | 0 | 0 | 0 |
|---|---|---|---|
| 2016 | 674.01K | -28.99K | 184.81K |
| 2017 | 1.53M | -282.91K | 527.44K |
| 2018 | -954.03K | -1.10M | 1.04M |
| 2019 | -627.05K | -2.92M | 13.29M |
| 2020 | 253K | -6.29M | 19.61M |
| 2021 | 570K | -5.60M | -270K |
| 2022 | 5.14M | -4.87M | -132K |
| 2023 | 1.31M | -4.20M | -239K |
DXRX.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 19.84M | 19.67M | 25.25M | 11.72M | 2.07M | 3.06M | 1.28M | 410.44K | 0 |
Operating activities | |||||||||
Net income | -1.74M | 724K | 561K | 263K | 397.88K | 632.30K | 784.85K | 784.97K | -103.48K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 4.77M | 3.00M | 1.79M | 809K | 284.85K | 117.68K | 26.58K | 167.53K | 0 |
Stock-based compensation expense | 445K | 536K | 373K | 290K | 24K | 405.92K | 134.31K | 173.29K | 0 |
| Deferred income tax benefit | 445K | 536K | 373K | 290K | 24K | 405.92K | 134.31K | 173.29K | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -2.15M | -1.59M | -1.49M | 549K | -2.32M | -2.55M | 171.67K | -1.11M | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 618K | 1.26M | -159K | -63K | 825.23K | 35.74K | 409.11K | 0 | 0 |
Cash generated by operating activities | 1.31M | 5.14M | 570K | 253K | -627.05K | -954.03K | 1.53M | 674.01K | 0 |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -125K | -4.87M | -5.60M | -6.29M | -2.92M | -1.10M | -282.91K | -29.03K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -4.20M | -4.87M | -5.60M | -6.29M | -2.92M | -1.10M | -282.91K | -28.99K | 0 |
Financing activities | |||||||||
Common Stock Issued | 0 | 129K | 0 | 19.61M | 16.03M | 10 | 0 | 28 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -300.21K | 0 | 0 | 0 |
Repurchases of common stock | -49K | -98K | -165K | 0 | 0 | 554.42K | 0 | -130.44K | 0 |
Repayments of term debt | 0 | 0 | -56K | 0 | -2.74M | -1.34M | 638.18K | -196.78K | 0 |
Cash used in financing activities | -239K | -132K | -270K | 19.61M | 13.29M | 1.04M | 527.44K | 184.81K | 0 |
Net Change In Cash | -3.17M | 166K | -5.58M | 13.53M | 9.64M | -995.22K | 1.78M | 875.32K | 0 |
Cash at end of period | 16.66M | 19.84M | 19.67M | 25.25M | 11.72M | 2.07M | 3.06M | 1.28M | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |